» Articles » PMID: 34543105

Shigella Flexneri Diguanylate Cyclases Regulate Virulence

Overview
Journal J Bacteriol
Specialty Microbiology
Date 2021 Sep 20
PMID 34543105
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Shigella flexneri is an intracellular human pathogen that invades colonic cells and causes bloody diarrhea. S. flexneri evolved from commensal Escherichia coli, and genome comparisons reveal that S. flexneri has lost approximately 20% of its genes through the process of pathoadaptation, including a disproportionate number of genes associated with the turnover of the nucleotide-based second messenger cyclic di-GMP (c-di-GMP); however, the remaining c-di-GMP turnover enzymes are highly conserved. c-di-GMP regulates many behavioral changes in other bacteria in response to changing environmental conditions, including biofilm formation, but this signaling system has not been examined in S. flexneri. In this study, we expressed VCA0956, a constitutively active c-di-GMP synthesizing diguanylate cyclase (DGC) from Vibrio cholerae, in S. flexneri to determine if virulence phenotypes were regulated by c-di-GMP. We found that expressing VCA0956 in S. flexneri increased c-di-GMP levels, and this corresponds with increased biofilm formation and reduced acid resistance, host cell invasion, and plaque size. We examined the impact of VCA0956 expression on the S. flexneri transcriptome and found that genes related to acid resistance were repressed, and this corresponded with decreased survival to acid shock. We also found that individual S. flexneri DGC mutants exhibit reduced biofilm formation and reduced host cell invasion and plaque size, as well as increased resistance to acid shock. This study highlights the importance of c-di-GMP signaling in regulating S. flexneri virulence phenotypes. The intracellular human pathogen causes dysentery, resulting in as many as one million deaths per year. Currently, there is no approved vaccine for the prevention of shigellosis, and the incidence of antimicrobial resistance among species is on the rise. Here, we explored how the widely conserved c-di-GMP bacterial signaling system alters behaviors associated with pathogenesis. We found that expressing or removing enzymes associated with c-di-GMP synthesis results in changes in 's ability to form biofilms, invade host cells, form lesions in host cell monolayers, and resist acid stress.

Citing Articles

Evolution of cyclic di-GMP signalling on a short and long term time scale.

Romling U, Cao L, Bai F Microbiology (Reading). 2023; 169(6).

PMID: 37384391 PMC: 10333796. DOI: 10.1099/mic.0.001354.


Identification of Antibacterial Components and Modes in the Methanol-Phase Extract from a Herbal Plant Wight et Arn.

Tang Y, Yu P, Chen L Foods. 2023; 12(8).

PMID: 37107435 PMC: 10137656. DOI: 10.3390/foods12081640.


YfiB: An Outer Membrane Protein Involved in the Virulence of .

Sen T, Verma N Microorganisms. 2022; 10(3).

PMID: 35336228 PMC: 8948675. DOI: 10.3390/microorganisms10030653.

References
1.
Massie J, Reynolds E, Koestler B, Cong J, Agostoni M, Waters C . Quantification of high-specificity cyclic diguanylate signaling. Proc Natl Acad Sci U S A. 2012; 109(31):12746-51. PMC: 3411991. DOI: 10.1073/pnas.1115663109. View

2.
Foster J . Escherichia coli acid resistance: tales of an amateur acidophile. Nat Rev Microbiol. 2004; 2(11):898-907. DOI: 10.1038/nrmicro1021. View

3.
Aldridge P, Paul R, Goymer P, Rainey P, Jenal U . Role of the GGDEF regulator PleD in polar development of Caulobacter crescentus. Mol Microbiol. 2003; 47(6):1695-708. DOI: 10.1046/j.1365-2958.2003.03401.x. View

4.
Carayol N, Tran van Nhieu G . The inside story of Shigella invasion of intestinal epithelial cells. Cold Spring Harb Perspect Med. 2013; 3(10):a016717. PMC: 3784809. DOI: 10.1101/cshperspect.a016717. View

5.
Kotloff K, Winickoff J, Ivanoff B, Clemens J, Swerdlow D, Sansonetti P . Global burden of Shigella infections: implications for vaccine development and implementation of control strategies. Bull World Health Organ. 1999; 77(8):651-66. PMC: 2557719. View